Attachment 2 - 60 day FRN

28939

Federal Register / Vol. 74, No. 116 / Thursday, June 18, 2009 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average burden per response (in
hours)

Number
of respondents

Number of responses per
respondent

Labs .................................................................................................................
Labs .................................................................................................................

660
330

2
1

10/60
30/60

220
165

Total ..........................................................................................................

........................

........................

........................

385

Respondents

Dated: June 11, 2009.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–14312 Filed 6–17–09; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day-09–0600]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects.
Alternatively, to obtain a copy of the
data collection plans and instrument,
call 404–639–5960 and send comments
to Maryam I. Daneshvar, CDC Reports
Clearance Officer, 1600 Clifton Road,
NE., MS–D74, Atlanta, Georgia 30333;
comments may also be sent by e-mail to
omb@cdc.gov.
Comments are invited on (a) whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarify of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of information technology. Written
comments should be received within 60
days of this notice.

VerDate Nov<24>2008

21:58 Jun 17, 2009

Jkt 217001

Proposed Project
Model Performance Evaluation
Program for Mycobacterium tuberculosis
and Non-tuberculous Mycobacterium
Drug Susceptibility Testing (OMB
Control No. 0920–0600, expiration date
03/31/2010)—Revision—National
Center for Preparedness, Detection, and
Control of Infectious Diseases
(NCPDCID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
As part of the continuing effort to
support both domestic and global public
health objectives for treatment of
tuberculosis (TB), prevention of multidrug resistance, and surveillance
programs, CDC is requesting approval
from the Office of Management and
Budget to continue data collection from
participants in the Model Performance
Evaluation Program for Mycobacterium
tuberculosis and Non-tuberculous
Mycobacterium Drug Susceptibility
Testing. This request includes changes
to the Results Form and re-introduction
of the Laboratory Practices
Questionnaire.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
The rate of TB cases detected in foreignborn persons has been reported to be
more than nine times higher than the
rate among the U.S. born population.
CDC’s goal to eliminate TB will be
virtually impossible without
considerable effort in assisting heavy
disease burden countries in the
reduction of tuberculosis. The Model
Performance Evaluation Program for
Mycobacterium tuberculosis and Nontuberculous Mycobacterium Drug
Susceptibility Testing program supports
this role by monitoring and evaluating
the level of performance and practices
among national and international

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

Total burden
(in hours)

laboratories performing M. tuberculosis
susceptibility testing. Participation in
this program is one way laboratories can
ensure high-quality laboratory testing,
resulting in accurate and reliable testing
results.
By providing an evaluation program
to assess the ability of the laboratories
to test for drug resistant M. tuberculosis
and selected strains of Non-tuberculous
Mycobacteria (NTM), laboratories also
have a self-assessment tool to aid in
optimizing their skills in susceptibility
testing. The information obtained from
laboratories on susceptibility testing
practices and procedures is used to
establish variables related to good
performance, assessing training needs,
and aid with the development of
practice standards.
Participants in this program include
domestic clinical and public health
laboratories and international
laboratories. Data collection from
domestic laboratory participants occurs
twice per year. Data collection from
international laboratories is limited to
those that have public health
responsibilities for tuberculosis drug
susceptibility testing and have obtained
approval to participate by their national
tuberculosis program. The data
collected in this program will include
the susceptibility test results of primary
and secondary drugs, drug
concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) samples.
The PE samples are sent to participants
twice a year. Participants also report
demographic data such as laboratory
type and the number of tests performed
annually. Participants report this data
every two years. The burden for the
Laboratory Practices Questionnaire has
been adjusted for the average per year,
since responses are received every other
year.
There is no cost to respondents to
participate other than their time.

E:\FR\FM\18JNN1.SGM

18JNN1

28940

Federal Register / Vol. 74, No. 116 / Thursday, June 18, 2009 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Labs ..................
Labs ..................

262
132

2
1

30/60
30/60

262
66

...........................

........................

........................

........................

328

Respondents

Susceptibility Testing Results Form .................................
Laboratory Practices Questionnaire .................................
Total ...........................................................................

Dated: June 11, 2009.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–14313 Filed 6–17–09; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Delegation of Authority
Notice is hereby given that I have
delegated to the Administrator,
Substance Abuse and Mental Health
Services Administration (SAMHSA),
with authority to redelegate, the
authorities vested in the Secretary of
Health and Human Services under
section 3990 of the Public Health
Service Act (42 U.S.C. 280g–3), as
amended hereafter, insofar as these
authorities pertain to the functions
assigned to SAMHSA.
These authorities shall be exercised
under the Department’s Policy on
regulations and the existing delegation
of authority to approve and issue
regulations.
In addition, I have affirmed and
ratified any actions taken by the
SAMHSA Administrator or by any other
SAMHSA officials, which, in effect,
involved the exercise of this authority
prior to the effective date of this
delegation.
This delegation is effective upon date
of signature.
Dated: June 5, 2009.
Kathleen Sebelius,
Secretary.
[FR Doc. E9–14219 Filed 6–17–09; 8:45 am]
BILLING CODE 4160–01–M

VerDate Nov<24>2008

21:58 Jun 17, 2009

Jkt 217001

DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2009–0086]

Science and Technology (S&T)
Directorate; Submission for Review;
Information Collection Request for the
DHS S&T SAFETY Act Program
AGENCY: Science and Technology
Directorate, DHS.
ACTION: 60-day Notice and request for
comment.

Substance Abuse and Mental Health
Services Administration

SUMMARY: The Department of Homeland
Security (DHS) invites the general
public to comment on the following
data collection forms for the DHS
Science and Technology Directorate’s
Support Anti-Terrorism by Fostering
Effective Technologies (SAFETY) Act
Program: Registration of a Seller of an
Anti-Terrorism Technology (DHS Form
10010), Request for a Pre-Application
Consultation (DHS Form 10009), Notice
of License of Qualified Anti-Terrorism
Technology (DHS Form 10003),
Application for Modification of
SAFETY Act Benefits (DHS Form
10002), Request for Transfer of SAFETY
Act Benefits (DHS Form 10001),
Application for SAFETY Act Renewal,
Application for SAFETY Act
Developmental Testing and Evaluation
(DT&E) Designation (DHS Form 10006),
Application for SAFETY Act
Designation (DHS Form 10008),
Application for SAFETY Act
Certification (DHS Form 10007),
Application for SAFETY Act Block
Designation (DHS Form 10005), and
Application for SAFETY Act Block
Certification (DHS Form 10004).
In 2002, The Support Anti-Terrorism
by Fostering Effective Technologies
(SAFETY) Act (6 CFR Part 25) was
enacted as part of the Homeland
Security Act of 2002, Public Law 107–
296. The SAFETY Act program
promotes the development and use of
anti-terrorism technologies that will
enhance the protection of the nation and
provides risk management and litigation
management protections for sellers of
Qualified Anti-Terrorism Technology
(QATT) and others in the supply and
distribution chain.

PO 00000

Average
burden
per response
(in hours)

Number
of respondents

Form

Frm 00062

Fmt 4703

Sfmt 4703

Total burden
(in hours)

The Department of Homeland
Security Science & Technology
Directorate (DHS S&T) currently has
approval to collect information for the
implementation of the SAFETY Act
program until January 31, 2010. With
this notice, DHS S&T seeks approval to
renew this information collection for
continued use after this date. The
SAFETY Act program requires the
collection of this information in order to
evaluate and qualify Anti-Terrorism
Technologies, based on the economic
and technical criteria contained in the
SAFETY Act Final Rule, for protection
in accordance with the Act, and
therefore encourage the development
and deployment of new and innovative
anti-terrorism products and services.
This notice and request for comments
is required by the Paperwork Reduction
Act of 1995 (Pub. L. 104–13, 44 U.S.C.
chapter 35).
DATES: Comments are encouraged and
will be accepted until August 17, 2009.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to Desk Officer for the Department of
Homeland Security, Science &
Technology Directorate, and sent via
electronic mail to
oira_submission@omb.eop.gov or faxed
to (202) 395–6974. Please include the
docket number [DHS–2009–0086] in the
subject line of the message.
FOR FURTHER INFORMATION CONTACT:
Michael Bowerbank, 202–254–6895.

DHS S&T
provides a secure website, accessible
through http://www.SAFETYAct.gov,
through which the public can learn
about the program, submit applications
for SAFETY Act protections, submit
questions to the Office of SAFETY Act
Implementation (OSAI), and provide
feedback. The data collection forms
have standardized the collection of
information that is both necessary and
essential for the DHS OSAI.

SUPPLEMENTARY INFORMATION:

E:\FR\FM\18JNN1.SGM

18JNN1